Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 3
2011 2
2012 3
2013 1
2014 2
2015 1
2016 1
2017 2
2018 1
2019 6
2020 2
2021 6
2022 4
2023 4
2024 3
2025 3
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for s nazarinia
Search for S Naserinia instead (1 results)
CSF levels of cytokines in neuro-Behcet's disease.
Borhani Haghighi A, Ittehadi H, Nikseresht AR, Rahmati J, Poorjahromi SG, Pourabbas B, Nazarinia MA, Habibagahi Z, Fattahi MJ, Ghaderi A. Borhani Haghighi A, et al. Clin Neurol Neurosurg. 2009 Jul;111(6):507-10. doi: 10.1016/j.clineuro.2009.02.001. Epub 2009 Mar 19. Clin Neurol Neurosurg. 2009. PMID: 19303205
BACKGROUND: Neurological manifestations of Behcet's disease (neuro-Behcet's disease) present in 5-30% of patients. Although cytokines play a pivotal role in pathogenesis of Behcet's disease, published studies about the cerebrospinal fluid (CSF) levels of cyto …
BACKGROUND: Neurological manifestations of Behcet's disease (neuro-Behcet's disease) present in 5-30% of patients. Although cy …
Indications, response, and side effects of biologic treatment in Behcet's disease: an 8-year study with follow-up.
Shenavandeh S, Aflaki E, Jahromi MR, Haghighi AB, Nazarinia MA. Shenavandeh S, et al. Reumatologia. 2024;62(2):101-108. doi: 10.5114/reum/183467. Epub 2024 Apr 5. Reumatologia. 2024. PMID: 38799775 Free PMC article.
INTRODUCTION: The treatment of Behcet's disease has improved significantly with the introduction of biologic therapies. However, there is still a need for more information about their use. ...CONCLUSIONS: We found a promising improvement at 6-month and 12-month follow-ups …
INTRODUCTION: The treatment of Behcet's disease has improved significantly with the introduction of biologic therapies. However, ther …
Efficacy and safety of the biosimilar denosumab candidate (Arylia) compared to the reference product (Prolia®) in postmenopausal osteoporosis: a phase III, randomized, two-armed, double-blind, parallel, active-controlled, and noninferiority clinical trial.
Jamshidi A, Vojdanian M, Soroush M, Akbarian M, Aghaei M, Hajiabbasi A, Mirfeizi Z, Khabbazi A, Alishiri G, Haghighi A, Salimzadeh A, Karimzadeh H, Shirani F, Fard MRH, Nazarinia M, Soroosh S, Anjidani N, Gharibdoost F. Jamshidi A, et al. Arthritis Res Ther. 2022 Jun 30;24(1):161. doi: 10.1186/s13075-022-02840-8. Arthritis Res Ther. 2022. PMID: 35773713 Free PMC article. Clinical Trial.
(-)-α-bisabolol exerts neuroprotective effects against pentylenetetrazole-induced seizures in rats by targeting inflammation and oxidative stress.
Nazarinia D, Moslehi A, Hashemi P. Nazarinia D, et al. Physiol Behav. 2023 Dec 1;272:114351. doi: 10.1016/j.physbeh.2023.114351. Epub 2023 Sep 14. Physiol Behav. 2023. PMID: 37714321
The seizure intensity was evaluated according to modifies Racine's convulsion scale (RCS). Y-maze and passive avoidance were utilized to assess working memory and aversive memory. ...
The seizure intensity was evaluated according to modifies Racine's convulsion scale (RCS). Y-maze and passive avoidance were utilized …
Infliximab for patients with neuro-Behcet's disease: case series and literature review.
Borhani Haghighi A, Safari A, Nazarinia MA, Habibagahi Z, Shenavandeh S. Borhani Haghighi A, et al. Clin Rheumatol. 2011 Jul;30(7):1007-12. doi: 10.1007/s10067-011-1726-1. Epub 2011 Mar 24. Clin Rheumatol. 2011. PMID: 21431864 Review.
This study aims to report the therapeutic effects of anti-tumor necrotic factor antibody, infliximab, for treatment of neuro-Behcet's disease (NBD) and to review the literature. We described four patients (all male, median age 40 years old) who fulfilled the International …
This study aims to report the therapeutic effects of anti-tumor necrotic factor antibody, infliximab, for treatment of neuro-Behcet's …
Is there any Sympathetic Skin Response Abnormality in Raynaud Phenomenon?
Emad MR, Farpour HR, Ahmed F, Tayebi M, Nazarinia M, Askarpour MR, Nikbakht HA. Emad MR, et al. Sultan Qaboos Univ Med J. 2022 May;22(2):274-279. doi: 10.18295/squmj.4.2021.066. Epub 2022 May 26. Sultan Qaboos Univ Med J. 2022. PMID: 35673285 Free PMC article.
RESULTS: The RP group consisted of 19 women (95%) and one male (5%); three patients (15%) had primary Raynaud's phenomenon (PRP) and 17 patients (85%) had secondary Raynaud's phenomenon. The control group consisted of 16 women (80%) and four males (20%). ...The find …
RESULTS: The RP group consisted of 19 women (95%) and one male (5%); three patients (15%) had primary Raynaud's phenomenon (PRP) and …
Neuroprotective effects of Royal Jelly (RJ) against pentylenetetrazole (PTZ)-induced seizures in rats by targeting inflammation and oxidative stress.
Nazarinia D, Karimpour S, Hashemi P, Dolatshahi M. Nazarinia D, et al. J Chem Neuroanat. 2023 Apr;129:102255. doi: 10.1016/j.jchemneu.2023.102255. Epub 2023 Mar 5. J Chem Neuroanat. 2023. PMID: 36878412
Seizure parameters were graded based on Racine's 7-point classification. Elevated-plus maze, Y maze and shuttle box tests were carried out to assess anxiety-like behavior, short-term memory, and passive avoidance memory, respectively. ...
Seizure parameters were graded based on Racine's 7-point classification. Elevated-plus maze, Y maze and shuttle box tests were carrie …
Scleroderma-overlap syndromes: capillaroscopy, laboratory, and clinical manifestations and follow-up compared to scleroderma patients.
Shenavandeh S, Azariyon Z, Nazarinia MA. Shenavandeh S, et al. Reumatologia. 2023;61(6):448-459. doi: 10.5114/reum/175508. Epub 2024 Jan 18. Reumatologia. 2023. PMID: 38322100 Free PMC article.
RESULTS: Of the 135 patients, 70 had SSc-OS, including 45 (64.3%) cases of SSc-SS (Sjogren's syndrome), 11 (15.7%) of SSc-RA (rheumatoid arthritis), 9 (12.9%) of SSc-myositis and 5 (1.7%) of SSc-SLE (systemic lupus erythematosus), and 65 had LcSSc. ...
RESULTS: Of the 135 patients, 70 had SSc-OS, including 45 (64.3%) cases of SSc-SS (Sjogren's syndrome), 11 (15.7%) of SSc-RA (rheumat …
42 results